title: Concomitant chronic pulmonary diseases and their association with hospital outcomes in patients with anaphylaxis and other allergic conditions: a cohort study.
abstract: OBJECTIVE
  To determine if chronic pulmonary diseases adversely impact selected outcomes in hospitalised patients who have various allergic conditions including anaphylaxis.
  
  
  METHODS
  A population-based cohort study.
  
  
  METHODS
  A statewide hospital inpatient discharge database from Texas, USA, covering the years 2004-2007 was analysed. Patients with anaphylaxis and other allergic conditions were identified using the International Classification of Diseases, Ninth Revision, Clinical Modification codes. Within each group of patients (the overall group with various selected allergic conditions and the subgroup with anaphylaxis), the exposure variables were 11 chronic pulmonary diseases including asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis.
  
  
  METHODS
  Admission to an intensive care unit, a prolonged (>3 days) hospital stay, receipt of mechanical ventilation and death in hospital. Logistic regression was used to calculate adjusted OR and 95% CI for these four outcomes.
  
  
  RESULTS
  30 390 patients with allergic conditions were identified, of whom 2410 had anaphylaxis. The following results pertain to the subcohort of patients with anaphylaxis. Median age was 50 years (range 0-95 years) and 1470 (61%) were female. The hospital mortality was 2.7%. Although asthma was not associated with hospital mortality (OR=1.27, 95% CI 0.55 to 2.90), asthmatics had more than twice the odds of non-asthmatics of receiving mechanical ventilation (OR=2.45, 95% CI 1.81 to 3.33). Chronic bronchitis, COPD, emphysema and interstitial lung diseases (ILDs) were also associated with an increased risk of requiring mechanical ventilation. Chronic bronchitis and COPD were associated with a prolonged length of stay: OR=2.69 (95% CI 1.45 to 4.98) and OR=1.86 (95% CI 1.30 to 2.66), respectively. ILD was the only chronic pulmonary disease associated with an elevated risk of hospital mortality: OR=8.71 (95% CI 1.48 to 51.20).
  
  
  CONCLUSIONS
  In this unique analysis of a large database, we found that asthma, COPD and other chronic pulmonary diseases increased the risk of adverse outcomes among hospitalised patients with anaphylaxis.
authors.affiliation: Department of Obstetrics and Gynecology, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, USA.
authors.forename: Zuber D
authors.initials: ZD
authors.lastname: Mulla
authors.forename: F Estelle R
authors.initials: FE
authors.lastname: Simons
references.citation: J Allergy Clin Immunol. 2001 Jan;107(1):191-3
references.pmid: 11150011
references.citation: Clin Exp Allergy. 2009 May;39(5):620-2
references.pmid: 19400907
references.citation: Am J Obstet Gynecol. 2006 Apr;194(4):992-1001
references.pmid: 16580288
references.citation: Forensic Sci Int. 2009 Apr 15;186(1-3):1-5
references.pmid: 19217731
references.citation: Ann Allergy Asthma Immunol. 2010 May;104(5):371-7
references.pmid: 20486326
references.citation: J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S161-81
references.pmid: 20176258
references.citation: J Allergy Clin Immunol. 2009 Mar;123(3):680-6
references.pmid: 19135713
references.citation: J Allergy Clin Immunol. 2006 Feb;117(2):391-7
references.pmid: 16461139
references.citation: J Allergy Clin Immunol. 2012 Mar;129(3):748-52
references.pmid: 22051698
references.citation: J Clin Epidemiol. 1996 Dec;49(12):1373-9
references.pmid: 8970487
references.citation: J Allergy Clin Immunol. 2010 Jul;126(1):98-104.e4
references.pmid: 20541247
references.citation: J Allergy Clin Immunol. 2007 Apr;119(4):1018-9
references.pmid: 17349682
references.citation: Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:240-7
references.pmid: 22262612
references.citation: N Engl J Med. 1992 Aug 6;327(6):380-4
references.pmid: 1294076
references.citation: Ann Epidemiol. 2002 Oct;12(7):452-4
references.pmid: 12377421
references.citation: Clin Exp Allergy. 2000 Aug;30(8):1144-50
references.pmid: 10931122
references.citation: Ann Allergy Asthma Immunol. 2006 Nov;97(5):596-602
references.pmid: 17165265
references.citation: J Allergy Clin Immunol. 2009 Mar;123(3):687-8
references.pmid: 19281912
references.citation: J Allergy Clin Immunol. 2010 May;125(5):1098-1104.e1
references.pmid: 20392483
references.citation: Immunol Allergy Clin North Am. 2007 May;27(2):145-63, v
references.pmid: 17493495
references.citation: J Allergy Clin Immunol. 2009 Nov;124(5):1047-54
references.pmid: 19895993
references.citation: J Allergy Clin Immunol. 2010 Jun;125(6):1269-1278.e2
references.pmid: 20434205
references.citation: JAMA. 1988 Sep 9;260(10):1450-2
references.pmid: 3404604
references.citation: Ann Allergy Asthma Immunol. 2007 Mar;98(3):252-7
references.pmid: 17378256
references.citation: J Allergy Clin Immunol. 2007 Jul;120(1 Suppl):S2-24
references.pmid: 17602945
references.citation: J Clin Pathol. 2000 Apr;53(4):273-6
references.pmid: 10823122
references.citation: J Allergy Clin Immunol. 2013 Apr;131(4):1103-8
references.pmid: 23453138
references.citation: J Registry Manag. 2012 Winter;39(4):167-71
references.pmid: 23493022
references.citation: J Allergy Clin Immunol. 2007 Apr;119(4):1016-8
references.pmid: 17306354
references.citation: Am J Public Health. 1992 Feb;82(2):243-8
references.pmid: 1739155
references.citation: J Allergy Clin Immunol. 2011 Mar;127(3):587-93.e1-22
references.pmid: 21377030
references.citation: Allergy. 2008 Feb;63(2):226-32
references.pmid: 18186813
references.citation: Ann Epidemiol. 2006 Sep;16(9):696-700
references.pmid: 16516491
references.citation: J Allergy Clin Immunol. 2008 Dec;122(6):1166-8
references.pmid: 19084110
references.citation: Int Arch Allergy Immunol. 2007;144(2):128-36
references.pmid: 17536221